Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Archive

Figures in the National Profile

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 

Chlamydia

Figure 1. Chlamydia—Rates by Sex, United States, 1991–2011

Figure 2. Chlamydia—Rates by Region, United States, 2002–2011

Figure 3. Chlamydia—Rates by State, United States and Outlying Areas, 2011

Figure 4. Chlamydia—Rates by County, United States, 2011

Figure 5. Chlamydia—Rates by Age and Sex, United States, 2011

Figure 6. Chlamydia—Rates by Race/Ethnicity, United States, 2002–2011

Figure 7. Chlamydia—Cases by Reporting Source and Sex, United States, 2002–2011

Figure 8. Chlamydia—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011

Figure 9. Chlamydia—Proprotion of Sexually Transmitted Disease (STD) Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2011

Figure 10. Chlamydia—Prevalence Among Persons Aged 14-39 Years by Sex and Survey Cycle, National Health and Nutrition Examination Survey, 1999-2008

Figure 11. Chlamydia—Prevalence Among Persons Aged 14-39 Years by Sex, Race/Ethnicity, or Age Group, National Health and Nutrition Examination Survey, 2005-2008

Figure 12. Chlamydia—Median State-specific Positivity Rates Among Women Aged 15-24 Years Tested in Family Planning Clinics, Infertility Prevention Project, United States, 1997-2011

Figure 13. Chlamydia—Positivity Among Women Aged 15-24 Years Tested In Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011

Figure 14. Chlamydia—Trends In Positivity Rates Among Women Aged 15-24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2007-2011

Figure 15. Chlamydia—Percentage of Nucleic Acid Amplification Tests Used Among Women Aged 15-24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2007-2011

Gonorrhea

Figure 16. Gonorrhea—Rates, United States, 1941–2011

Figure 17. Gonorrhea—Rates by Sex, United States, 1991–2011

Figure 18. Gonorrhea—Rates by Region, United States, 2002–2011

Figure 19. Gonorrhea—Rates by State, United States and Outlying Areas, 2011

Figure 20. Gonorrhea—Rates by County, United States, 2011

Figure 21. Gonorrhea—Rates by Age and Sex, United States, 2011

Figure 22. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2002–2011

Figure 23. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2002–2011

Figure 24. Gonorrhea—Rates by Race/Ethnicity, United States, 2002–2011

Figure 25. Gonorrhea—Cases by Reporting Source and Sex, United States, 2002–2011

Figure 26. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011

Figure 27. Proportion of MSM, MSW, and Women Among Interviewed Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2011

Figure 28. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011

Figure 29. Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP) United States, 2011

Figure 30. Distribution of Minimum Inhibitory Concentrations (MICs) of Ceftriaxone Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2007–2011

Figure 31. Distribution of Minimum Inhibitory Concentrations (MICs) of Cefixime Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2009–2011

Figure 32. Distribution of Minimum Inhibitory Concentrations (MICs) of Azithromycin Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2007–2011

Figure 33. Percentage of Neisseria gonorrhoeae Isolates that are Cirpofloxacin-Resistant by Sex of Sex Partner, Gonococcal Isolate Surveillance Project (GISP) 1995–2011

Figure 34. Penicillin, Tetracycline, and Ciprofloxacin Resistance Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2011

Figure 35. Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP)—1988–2011

Syphilis

Figure 36. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2011

Figure 37. Primary and Secondary Syphilis—by Sex and Sexual Behavior, 33 Areas 2007–2011

Figure 38. Primary and Secondary Syphilis —Rates by Sex and Male-to-Female Rate Ratios, United States, 1990-2011

Figure 39. Primary and Secondary Syphilis—Rates by Region, United States, 2002–2011

Figure 40. Primary and Secondary Syphilis—Rates by State, United States and Outlying Areas, 2011

Figure 41. Primary and Secondary Syphilis—Rates by County, United States, 2011

Figure 42. Primary and Secondary Syphilis—Rates by Age and Sex, United States, 2011

Figure 43. Primary and Secondary Syphilis—Rates by Age Among Women Aged 15–44 Years, United States, 2002–2011

Figure 44. Primary and Secondary Syphilis—Rates by Age Among Men Aged 15–44 Years, United States, 2002–2011

Figure 45. Primary and Secondary Syphilis—Rates by Race/Ethnicity, United States, 2002–2011

Figure 46. Primary and Secondary Syphilis—Reported Cases by Stage, Sex, and Sexual Behavior, United States, 2011

Figure 47. Primary and Secondary Syphilis—Reported Cases by Sex, Sexual Behavior, and Race/Ethnicity, United States, 2011

Figure 48. Primary and Secondary Syphilis—Reported Cases by Reporting Source and Sex, United States, 2002–2011

Figure 49. Primary and Secondary Syphilis—Percentage of Reported Cases by Sex, Sexual Behavior, and Selected Reporting Sources, 2011

Figure 50. Congenital Syphilis—Reported Cases Among Infants by Year of Birth and Rates of Primary and Secondary Syphilis Among Women, United States, 2002–2011

Other Sexually Transmitted Diseases

Figure 51. Chancroid—Reported Cases, United States, 1981–2011

Figure 52. Human Papillomavirus—Prevalence of High-risk and Low-risk Types Among Females Aged 14–59 Years, National Health and Nutrition Examination Survey, 2003–2006

Figure 53. Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2011

Figure 54. Genital Warts—Prevalence Among Sexually Transmitted Disease (STD) Clinic Patients by Sex, Sex of Partners, and Site, STD Surveillance Network (SSuN), 2011

Figure 55. Genital Herpes—Initial Visits to Physicians’ Offices, United States, 1966–2011

Figure 56. Herpes Simplex Virus Type 2—Seroprevalence in Non-Hispanic Whites and Non-Hispanic Blacks by Age Group, National Health and Nutrition Examination Survey, 1976–1980, 1988–1994, 1999–2004, 2005–2008

Figure 57. Trichomoniasis and Other Vaginal Infections—Women—Initial Visits to Physicians’ Offices, United States, 1966–2011

Related Links

Follow STD

Top